Infectious Diseases Therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Cellulitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... provides comprehensive information on the therapeutics under development for Cellulitis, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers t......" | 02-May-2022 | $2000 | |
Pneumocystis Pneumonia (Pneumocystosis-Pneumocystis jiroveci Pneumonia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... oA, RoA, Molecule Type and Key Players provides an overview of the Pneumocystis Pneumonia (Pneumocystosis/Pneumocystis jiroveci Pneumonia) pipeline landscape.
The report provides comprehensive information on the therapeutics under develo......" | 02-May-2022 | $2000 | |
Cerebral (Fatal) Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... peline landscape.
The report provides comprehensive information on the therapeutics under development for Cerebral (Fatal) Malaria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administ......" | 02-May-2022 | $2000 | |
Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Rift Valley Fever, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2000 | |
Salmonella typhimurium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... a typhimurium Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Salmonella typhimurium Infections, complete with analysis by Stage of Development, Drug Target, Mechanis......" | 02-May-2022 | $2000 | |
Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... of the Skin And Skin Structure Infections (SSSI) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Skin And Skin Structure Infections (SSSI), complete with analysis by Stage of De......" | 02-May-2022 | $2000 | |
Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... e Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Enterobacteriaceae Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 02-May-2022 | $2500 | |
Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Community-Acquired Bacterial Pneumonia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Community-Acquired Bacterial Pneumonia, complete with analysis by Stage of Development, D......" | 02-May-2022 | $2000 | |
Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Complicated Intra-Abdominal Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Complicated Intra-Abdominal Infections, complete with analysis by Stage of Development, D......" | 02-May-2022 | $2000 | |
Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... as Aeruginosa Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pseudomonas Aeruginosa Infections, complete with analysis by Stage of Development, Drug Target, Mechanis......" | 02-May-2022 | $2500 | |
|